INNOVATE Corp. (VATE)
CIK 1006837 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 13.6M shares as of Aug 3, 2026 (10-Q). Share count fell from 130.5M to 13.3M between Aug 2, 2024 and Nov 1, 2024, a pattern consistent with a reverse split (roughly 1-for-10); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
Warrants outstanding: 2.2M underlying shares, as reported Dec 31, 2019 (10-K).
Reported exercise price: $6.53 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $8.8M as of Oct 24, 2019.
Rough fully diluted estimate: 15.8M = 13.6M O/S + 2.2M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Senior Notes Due 202710.50 | $360.4M | $379.3M | not tagged | 10.5% | ~18.9M sh |
| Convertible Senior Notes Due 20279.50 | $2.3M | $56.0M | $42.31 | 9.5% | ~54,361 sh |
| Convertible Senior Notes Due 2026750 | $2.0M | $200,000 | $42.31 | 7.5% | ~47,270 sh |
If every note above converted at its tagged price: ~19.0M new shares on 13.6M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 13.6M | Aug 3, 2026 |
| + Warrants (aggregate, as tagged) (if exercised) | 2.2M | Dec 31, 2019 |
| + Senior Notes Due 202710.50 (if fully converted) | 18.9M | Aug 31, 2025 |
| + Convertible Senior Notes Due 20279.50 (if fully converted) | 54,361 | Jun 30, 2026 |
| + Convertible Senior Notes Due 2026750 (if fully converted) | 47,270 | Jun 30, 2026 |
| Fully diluted estimate | 34.8M | +155.3% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $100.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 1 executed · 1 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full VATE workspace